Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension

TY - JOUR

T1 - Use of direct oral anticoagulants prevents increase in pulmonary vascular resistance and incidence of clinical worsening in patients with chronic thromboembolic pulmonary hypertension

AU - Hosokawa, Kazuya

AU - Abe, Kohtaro

AU - Tsutsui, Hiroyuki

N1 - Funding Information: Kohtaro Abe worked in a department endowed by Actelion Pharmaceuticals Japan, and received a research grant from Mochida Pharmaceutical Co., Ltd. Hiroyuki Tsutsui received honoraria from Daiichi Sankyo, Inc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Boehringer Ingelheim Japan, Inc., Novartis Pharma K.K., Bayer Yakuhin, Ltd., Bristol-Myers Squibb KK, and Astellas Pharma Inc., and research funding from Actelion Pharmaceuticals Japan, Daiichi Sankyo, Inc., and Astellas Pharma Inc. Funding Information: This research was supported by Japan Agency for Medical Research and Development , Japan under Grant Number JP18ek0109371 .

PY - 2019/8

Y1 - 2019/8

UR - http://www.scopus.com/inward/record.url?scp=85067055281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067055281&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2019.05.018

DO - 10.1016/j.thromres.2019.05.018

M3 - Letter

C2 - 31200342

AN - SCOPUS:85067055281

SN - 0049-3848

VL - 180

SP - 43

EP - 46

JO - Thrombosis Research

JF - Thrombosis Research

ER -